Hepatitis B virus reactivation after kidney transplantation and new onset lymphoma.

A case of hepatitis B virus (HBV) reactivation after kidney transplantation is reported. The presence of antibodies against hepatitis B surface antigen (HBsAg) and hepatitis B core antigen (HBcAg) before transplantation indicated previous infection with HBV. Eight years after transplantation, a diffuse, large B-cell lymphoma occurred, and the patient was positive for HBsAg and hepatitis B e antigen, in association with normal activity of serum aminotransferases. Postmortem liver histology did not show any sign of portal tract or lobular inflammation despite the presence at immunostaining of extensive intranuclear and cytoplasmic positivity for HBcAg, indicating active viral replication. Natural immunity to HBV may not protect against reactivation in patients with a suppressed immune system. In this setting, periodic follow-up of HBV serology in patients at highest risk for HBV reactivation to allow for early diagnosis and prompt treatment with lamivudine is highly recommended.

[1]  H. Einsele,et al.  Successful antiviral treatment for fulminant reactivated hepatitis B after autologous stem cell transplantation and prophylaxis during subsequent allogeneic stem cell transplantation , 2002, Annals of Hematology.

[2]  M. Asaka,et al.  Lamivudine treatment for reverse seroconversion of hepatitis B 4 years after allogeneic bone marrow transplantation , 2002, Bone Marrow Transplantation.

[3]  G. Rossi,et al.  Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy , 2001, British journal of haematology.

[4]  T. Ueda,et al.  Successful lamivudine therapy for post-chemotherapeutic fulminant hepatitis B in a hepatitis B virus carrier with non-Hodgkin's lymphoma: case report and review of the literature , 2001, Annals of Hematology.

[5]  R. Perrillo.  Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. , 2001, Gastroenterology.

[6]  W. Yang,et al.  RESULTS ON PREEMPTIVE OR PROPHYLACTIC TREATMENT OF LAMIVUDINE IN HBsAg (+) RENAL ALLOGRAFT RECIPIENTS: COMPARISON WITH SALVAGE TREATMENT AFTER HEPATIC DYSFUNCTION WITH HBV RECURRENCE , 2001, Transplantation.

[7]  K. Kidd‐Ljunggren,et al.  Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation. , 2000, Journal of hepatology.

[8]  M. Lai,et al.  Managing hepatitis B reactivation in renal transplant recipients: a 12-year review with emphasis on early detection and early use of lamivudine. , 2000, Transplantation proceedings.

[9]  A. Keating,et al.  Overview of autologous stem cell transplantation. , 2000, Critical reviews in oncology/hematology.

[10]  S. Fukuda,et al.  [Prevention of hepatitis B flare-up using lamivudine in a patient with non-Hodgkin's lymphoma after allogeneic bone marrow transplantation]. , 2000, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[11]  A. Waage,et al.  Reactivation of hepatitis B virus infection in an anti-HBc and anti-HBs positive patient after allogeneic bone marrow transplantation. , 2000, European journal of haematology.

[12]  T. Koike,et al.  [Reactivation of hepatitis B virus after autologous peripheral blood stem cell transplantation in patients with positive hepatitis B surface antibodies]. , 2000, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[13]  D. Samuel,et al.  Hepatitis and solid organ transplantation. , 2000, Transplantation proceedings.

[14]  D. Verhelst,et al.  Lamivudine for the treatment of chronic hepatitis B. , 2000, The New England journal of medicine.

[15]  A. Waage,et al.  Reactivation of hepatitis B virus infection in an anti-HBc and anti-HBs positive patient after allogeneic bone marrow transplantation. , 2000, European journal of haematology.

[16]  S. Belle,et al.  Transplantation in the hepatitis B patient and current therapies to prevent recurrence. , 2000, Seminars in liver disease.

[17]  H. Ohno,et al.  Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period , 2000, Bone Marrow Transplantation.

[18]  P. Colombat,et al.  Acute hepatitis B after autologous stem cell transplantation in a man previously infected by hepatitis B virus , 1999, Bone Marrow Transplantation.

[19]  O. Simonsen,et al.  Reappearance of hepatitis B 10 years after kidney transplantation. , 1999, The New England journal of medicine.

[20]  F. Zoulim,et al.  Réactivation virale B après greffe de moelle allogénique chez un malade précédemment guéri d'une hépatite virale B. , 1999 .

[21]  R. Liang,et al.  Hepatitis B virus infection and bone marrow transplantation. , 1999, Critical reviews in oncology/hematology.

[22]  F. Zoulim,et al.  [Hepatitis B virus reactivation after allogeneic bone marrow transplantation in a patient previously cured of hepatitis B]. , 1999, Gastroenterologie clinique et biologique.

[23]  P. Vereerstraeten,et al.  Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: report on three cases and review of the literature. , 1998, Transplantation.

[24]  C. Rieux,et al.  Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc. , 1998, Transplantation.

[25]  T. Benzing,et al.  Occurrence and management of hepatitis B virus reactivation following kidney transplantation. , 1998, Clinical nephrology.

[26]  M. Picardi,et al.  Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation , 1998, Bone Marrow Transplantation.

[27]  A. Alberti,et al.  Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: a 10-year prospective study. , 1997, Blood.

[28]  D. Samuel,et al.  De novo and apparent de novo hepatitis B virus infection after liver transplantation. , 1997, Journal of hepatology.

[29]  F. Chisari,et al.  The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response , 1996, Nature Medicine.

[30]  K. Hasegawa,et al.  A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B. , 1996, Hepatology.

[31]  F. Lucht,et al.  [Reactivation of hepatitis B in AIDS]. , 1996, Presse medicale.

[32]  J. Dipersio,et al.  Hepatitis B reactivation following allogeneic bone marrow transplantation: case report and review of the literature. , 1995, Bone marrow transplantation.

[33]  C. Tzeng,et al.  Reactivation of hepatitis B virus in two chronic GVHD patients after transplant. , 1993, International journal of hematology.

[34]  M. Loriot,et al.  Redevelopment of hepatitis B surface antigen after renal transplantation. , 1991, Gastroenterology.

[35]  K. Okochi,et al.  Immunoselected hepatitis B virus mutant , 1991, The Lancet.

[36]  R. Poupon,et al.  [Reactivation of B hepatitis in an anti-HBs positive patient in HIV co-infection]. , 1991, Annales de medecine interne.

[37]  A. Lok,et al.  Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. , 1991 .

[38]  C. Tzeng,et al.  CHANGING OF HEPATITIS B VIRUS MARKERS IN PATIENTS WITH BONE MARROW TRANSPLANTATION , 1990, Transplantation.

[39]  P. Ferenci,et al.  Recurrence of hepatitis B in children with serologic evidence of past hepatitis B virus infection undergoing antileukemic chemotherapy. , 1989, Journal of hepatology.

[40]  H. Prentice,et al.  Fatal hepatitis B reactivation after autologous bone marrow transplantation. , 1989, Bone marrow transplantation.

[41]  J. Delfraissy,et al.  Reappearance of hepatitis B virus in immune patients infected with the human immunodeficiency virus type 1. , 1988, The Journal of infectious diseases.

[42]  D. Normansell,et al.  Hepatitis B virus serology. Loss of antibody to surface antigen. , 1987, American journal of clinical pathology.

[43]  J. Wands,et al.  Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. , 1985, The New England journal of medicine.

[44]  A. Alberti,et al.  Hepatitis B virus markers in children with acute leukemia: The effect of chemotherapy , 1985, Journal of medical virology.

[45]  R. Elliott.  WRINKLING OF SKIN IN CYSTIC FIBROSIS , 1974 .